Successful Treatment of Idiopathic Multicentric Castleman Disease With Rash as the Initial Symptom Using a Rituximab-Based Regimen [0.03%]
以皮疹为首发症状的多中心型Castleman病成功采用利妥昔单抗为基础方案治疗病例报告
Li Zhu,Yi Liu,Fang Yu et al.
Li Zhu et al.
Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder characterized by enlarged lymph nodes and systemic inflammation, often involving multiple organ dysfunction. However, cutaneous involvement in iMCD is r...
Case Reports
Journal of hematology. 2024 Oct;13(5):245-249. DOI:10.14740/jh1313 2024
Freedom From Bleeds With Low-Dose Emicizumab Prophylaxis in Inhibitor-Positive Hemophilia A [0.03%]
低剂量emicizumab预防性治疗在阳性抑制物甲型血友病患者中的应用可避免出血事件
Nita Radhakrishnan,Archit Pandharipande,Savitri Singh et al.
Nita Radhakrishnan et al.
Background: The real-world data on outcome of hemophilia A patients with inhibitors (HAI) is sparse, especially from developing countries. In a setting of inequitable healthcare opportunities for hemophilia patients, espe...
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience [0.03%]
伊立替康治疗多中心型卡斯特利曼病的现实世界研究经验
Ciprian Jitaru,Argyris Symeonidis,Sorina Badelita et al.
Ciprian Jitaru et al.
Background: Castleman disease (CD) is a very rare, non-malignant lymphoproliferative disorder that can be classified as unicentric or multicentric (MCD). MCD is associated with systemic symptoms, including organ dysfuncti...
Breast Cancer With Release of Tumor Cells in Peripheral Blood Mimicking Acute Myeloid Leukemia [0.03%]
乳腺癌伴肿瘤细胞外周血溢出类似急性髓系白血病
Arianna Gatti,Bruno Brando,Irene Cuppari et al.
Arianna Gatti et al.
A 75-year-old woman with a history of lobular breast adenocarcinoma treated with mastectomy and radiotherapy in 2021 and on maintenance hormone therapy, presented with asthenia and tremors. Laboratory tests showed leucocytosis, anemia and l...
Case Reports
Journal of hematology. 2024 Aug;13(4):168-173. DOI:10.14740/jh1259 2024
Zoe McKinnell,Daniel Tuerff,Mustafa Hammudi et al.
Zoe McKinnell et al.
Background: Age is a strong prognostic factor in acute lymphocytic leukemia (ALL), with children doing better than adults with the same disease. One hypothesis for this age-based disparity is differences in treatment regi...
David Green
David Green
Deficiencies of factor VIII (FVIII)/von Willebrand factor (VWF) or factor IX (FIX) are underappreciated as potential reasons for heavy menstrual bleeding, recurrent nosebleeds, and easy bruising in girls and women. Bleeding is usually not a...
Is There a Correlation Between Immune Thrombocytopenia and Immunoglobulin G4-Related Disease? [0.03%]
免疫性血小板减少症与IgG4相关疾病的相关性研究
Dorela Lame,Michelangelo Pianelli,Erika Morsia et al.
Dorela Lame et al.
Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition causing organ swelling and fibrosis. Rarely, it coexists with primary immune thrombocytopenia (ITP), characterized by low platelet count (< 100 × 106/L) without an...
Case Reports
Journal of hematology. 2024 Aug;13(4):174-177. DOI:10.14740/jh1260 2024
Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia [0.03%]
艾曲波帕联合一线免疫抑制剂治疗新诊断的重度再生障碍性贫血长期疗效分析
Hirofumi Yokota,Kotaro Miyao,Masashi Sawa et al.
Hirofumi Yokota et al.
Background: To investigate whether the addition of eltrombopag (EPAG) to rabbit anti-thymocyte globulin (ATG)-based immunosuppressive therapy (IST) for newly diagnosed severe aplastic anemia (SAA) improves outcomes and af...
Maria Pantelidou,Eleni Dimitriou,Konstantinos Gkontopoulos et al.
Maria Pantelidou et al.
Multiple myeloma is a plasma cell dyscrasia with an age-standardized incidence of 3 - 4 per 100,000 in the Caucasian population. It is the second most common hematological malignancy after non-Hodgkin lymphoma, representing 1% of all cancer...
Case Reports
Journal of hematology. 2024 Aug;13(4):164-167. DOI:10.14740/jh1267 2024
A Case of Autoimmune Myelofibrosis Associated With Autoimmune Hepatitis [0.03%]
一例与自身免疫性肝炎相关的自身免疫性骨髓纤维化病例
Hailey Tyndall,Lawrence Worobetz,Matthew Nicholson
Hailey Tyndall
Autoimmune myelofibrosis (AIMF) is a distinct, underrecognized, and rare cause of bone marrow fibrosis. It carries a favorable outcome and responds well to immunosuppression. Systemic lupus erythematosus is the most common association with ...
Case Reports
Journal of hematology. 2024 Aug;13(4):158-163. DOI:10.14740/jh1297 2024